{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:12:25Z","timestamp":1792019545375,"version":"4.4.0"},"reference-count":33,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Centre, Poland","award":["2020\/04\/X\/NZ7\/00104"],"award-info":[{"award-number":["2020\/04\/X\/NZ7\/00104"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objectives: Cardiovascular disease (CVD) remains the leading cause of death worldwide and requires a deeper understanding of its pathogenesis for effective prevention and treatment. Familial hypercholesterolemia (FH), characterized by high levels of LDL cholesterol, is a significant risk factor for CVD. FH background remains unexplained despite advances in genetic testing. The aim was identification early changes in the plasma lipidome of individuals at high cardiovascular risk (HCVR) using liquid chromatography coupled with mass spectrometry. Methods: The lipidomic analysis examined over 400 compounds. Twenty individuals with suspected FH, very high cardiovascular risk (VHCVR), and undetectable mutations in the LDLR, APOB, or PCSK9 genes were compared to control group in a qualitative-quantitative analysis. Results: Multivariate analyses revealed statistically significant alterations in glycerophospholipids (GC), with a notable increase in phosphatidylcholines ((O-36:0\/16:0), OR (95% CI): 1.246 (1.042\u20131.490), p = 0.0157), phosphatidylethanolamines ((O-40:7\/22:6), OR (95% CI): 1.119 (1.039\u20131.205), p = 0.0028), and phosphatidylglycerol ((40:8\/20:4), OR (95% CI): 1.053 (1.008\u20131.101), p = 0.0219) only in patients with HCVR. These changes, particularly in major classes of GC, underscored their potential as biomarkers for early assessment of cardiovascular risk. Lipidomic profiling revealed associations between specific lipid species and the comorbidities of arterial hypertension, atherosclerosis, and insulin resistance, implicating their role in atherosclerotic cardiovascular disease (ASCVD). Conclusions: This study points early changes in the plasma lipidome in individuals at HCVR, underline potential biomarkers, therapeutic targets for ASCVD, and offer opportunities to improve ASCVD diagnosis, therapy, and risk management strategies through detailed personalized medical approach.<\/jats:p>","DOI":"10.3390\/biomedicines13030643","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T06:02:13Z","timestamp":1741240933000},"page":"643","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Early Changes in the Plasma Lipidome of People at Very High Cardiovascular Risk: A New Approach to Assessing the Risk of Cardiovascular Changes"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4904-6398","authenticated-orcid":false,"given":"Joanna","family":"Wa\u015b","sequence":"first","affiliation":[{"name":"Department of Medical Biology, National Institute of Cardiology, State Research Institute, 42 Alpejska Str., 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Dobrowolski","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Cardiovascular Disease Prevention and Health Promotion, National Institute of Cardiology, State Research Institute, 42 Alpejska Str., 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Prejbisz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Cardiovascular Disease Prevention and Health Promotion, National Institute of Cardiology, State Research Institute, 42 Alpejska Str., 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Niedolistek","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, National Institute of Cardiology, State Research Institute, 42 Alpejska Str., 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-5109","authenticated-orcid":false,"given":"Ilona","family":"Kowalik","sequence":"additional","affiliation":[{"name":"Clinical Research Support Centre, National Institute of Cardiology, State Research Institute, 42 Alpejska Str., 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0998-4291","authenticated-orcid":false,"given":"Anna","family":"Drohomirecka","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplantology Clinic, National Institute of Cardiology, State Research Institute, 42 Alpejska Str., 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Soko\u0142owska","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, National Institute of Cardiology, State Research Institute, 42 Alpejska Str., 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7200-6178","authenticated-orcid":false,"given":"Jolanta","family":"Krzyszto\u0144-Russjan","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, National Institute of Cardiology, State Research Institute, 42 Alpejska Str., 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1038\/s41467-023-41963-7","article-title":"Metabolic phenotyping of BMI to characterize cardiometabolic risk: Evidence from large population-based cohorts","volume":"14","author":"Beyene","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2014.02.001","article-title":"Lipidomics: Potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease","volume":"143","author":"Meikle","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Gu, P.S., Su, K.W., Yeh, K.W., Huang, J.L., Lo, F.S., and Chiu, C.Y. (2023). Metabolomics Analysis Reveals Molecular Signatures of Metabolic Complexity in Children with Hypercholesterolemia. Nutrients, 15.","DOI":"10.3390\/nu15071726"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16248","DOI":"10.20452\/pamw.16248","article-title":"Atherosclerotic cardiovascular disease burden in patients with familial hypercholesterolemia: Interpretation of data on involvement of different vascular beds","volume":"132","author":"Dobrowolski","year":"2022","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/eurheartj\/ehad161","article-title":"Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction","volume":"44","author":"Nurmohamed","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: From mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e128438","DOI":"10.1172\/jci.insight.128438","article-title":"Changes in plasma lipids predict pravastatin efficacy in secondary prevention","volume":"4","author":"Jayawardana","year":"2019","journal-title":"JCI Insight"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e121326","DOI":"10.1172\/jci.insight.121326","article-title":"Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention","volume":"3","author":"Mundra","year":"2018","journal-title":"JCI Insight"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbalip.2011.06.009","article-title":"Lipid classification, structures and tools","volume":"1811","author":"Fahy","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/iub.337","article-title":"The Kennedy pathway\u2014De novo synthesis of phosphatidylethanolamine and phosphatidylcholine","volume":"62","author":"Gibellini","year":"2010","journal-title":"IUBMB Life"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4829180","DOI":"10.1155\/2017\/4829180","article-title":"Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease","volume":"2017","author":"Patel","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOL.0b013e3282fee935","article-title":"Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis","volume":"19","author":"Vance","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2020.06.049","article-title":"Advances in lipidomics","volume":"510","author":"Avela","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acs.jproteome.2c00682","article-title":"Comprehensive Lipidomic Workflow for Multicohort Population Phenotyping Using Stable Isotope Dilution Targeted Liquid Chromatography-Mass Spectrometry","volume":"22","author":"Ryan","year":"2023","journal-title":"J. Proteome Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11306-009-0174-2","article-title":"Effects of sample handling and storage on quantitative lipid analysis in human serum","volume":"5","author":"Zivkovic","year":"2009","journal-title":"Metabolomics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/gepi.22183","article-title":"A simple and accurate method to determine genomewide significance for association tests in sequencing studies","volume":"43","author":"Lin","year":"2019","journal-title":"Genet. Epidemiol."},{"key":"ref_18","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wang, J., Xu, J., Liu, T., Yu, C., Xu, F., Wang, G., Li, S., and Dai, X. (2024). Biomechanics-mediated endocytosis in atherosclerosis. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1337679"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Vinces, S., Garcia, P.H.D., Silva, A.A.R., Fernandes, A.M.A.P., Barreto, J.A., Duarte, G.H.B., Antonio, M.A., Birbrair, A., Porcari, A.M., and Carvalho, P.O. (2023). Mass-Spectrometry-Based Lipidomics Discriminates Specific Changes in Lipid Classes in Healthy and Dyslipidemic Adults. Metabolites, 13.","DOI":"10.3390\/metabo13020222"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mas.21627","article-title":"High resolution mass spectrometry in lipidomics","volume":"40","year":"2021","journal-title":"Mass Spectrom. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100138","DOI":"10.1016\/j.jlr.2021.100138","article-title":"Recommendations for good practice in MS-based lipidomics","volume":"62","author":"Ahrends","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1194\/jlr.R046094","article-title":"Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells","volume":"55","author":"Hishikawa","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1161\/ATVBAHA.111.234096","article-title":"Plasma lipidomic analysis of stable and unstable coronary artery disease","volume":"31","author":"Meikle","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11883-010-0110-y","article-title":"Lipidomics: A tool for studies of atherosclerosis","volume":"12","author":"Ekroos","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Karu, N., Kindt, A., Singh, M., Lamont, L., van Gammeren, A.J., Ermens, A.A.M., Harms, A.C., Portengen, L., and Vermeulen, R.C.H. (2024). Association of Altered Plasma Lipidome with Disease Severity in COVID-19 Patients. Biomolecules, 14.","DOI":"10.3390\/biom14030296"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","article-title":"Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study","volume":"129","author":"Stegemann","year":"2014","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-4939-7592-1_12","article-title":"Shotgun Lipidomics Approach for Clinical Samples","volume":"1730","author":"Eggers","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100127","DOI":"10.1016\/j.jlr.2021.100127","article-title":"Clinical lipidomics: Realizing the potential of lipid profiling","volume":"62","author":"Meikle","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/eurjpc\/zwaa143","article-title":"Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome","volume":"29","author":"Gencer","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Timmerman, N., Waissi, F., Dekker, M., de Borst, G.J., van Bennekom, J., de Winter, R.J., Hilvo, M., Jylh\u00e4, A., Pasterkamp, G., and de Kleijn, D.P.V. (2022). Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-09225-6"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.5114\/aoms\/152921","article-title":"Metabolic syndrome\u2014A new definition and management guidelines: A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, \u201cClub 30\u201d Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons","volume":"18","author":"Dobrowolski","year":"2022","journal-title":"Arch. Med. Sci."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/3\/643\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:48:01Z","timestamp":1760028481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/3\/643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["biomedicines13030643"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13030643","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}